Ehave owns approximately 9,793,754 shares of Mycotopia Therapies valued at more than $24 million, as of Friday’s closing price; Plans partial distribution...
Entities on track to merge under PSLY.com and list on NASDAQ Stock Exchange...
MIAMI, May 09, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA), a biopharma company focused on research, technology, and the...
Driving factors for growth in the European psychedelics market include growing acceptance of psychedelic medicine for treating depression and increasing...
Mycotopia Therapies and Ei.Ventures are moving forward with plans to form PSLY.COM; HAVN Life Sciences' functional mushrooms will be used in PSLY.COM’s...
Mycotopia Therapies plans to distribute HAVN’s line of natural OTC health products currently being registered with the Jamaican Ministry of Health...
Purchase to be named PSLY.COM represents the third largest land sale in the Metaverse valued at $2.2M ...
Post-acquisition company would focus on Ei.Ventures’ flagship product Psilly, a whole-plant Botanical Psilocybin-based formulation, which is currently in...
MIAMI, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology,...
MIAMI, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”) today announced the appointment of Saphire Longmore...